Deng G, Wang R, Sun Y, Huang CP, et al. Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPARgamma/MMP-9 signals. Cell Death Differ 2021 Jun 14. pii: 10.1038/s41418-021-00743.
PMID: 34127806